Memphis Pharmaceuticals & Chemical Industries reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was EGP 429.79 million compared to EGP 302.65 million a year ago. Net income was EGP 82.89 million compared to EGP 27.56 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
83.73 EGP | 0.00% | +7.94% | +33.52% |
1st Jan change | Capi. | |
---|---|---|
+33.52% | 9.99M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2023